converting from semaglutide to tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Semaglutide to Tirzepatide Dosing :

This may indicate volume depletion requiring IV hydration or electrolyte abnormalities needing lab confirmation

Oral versions of GLP-1s have also been approved, though they thus far have lower efficacy

2c and Supplementary Table 8), 105156 weeks ( n = 3, one trial each for liraglutide 31 , orlistat 32 and semaglutide 17 reporting a placebo-subtracted TBWL of 4.2%, 3.0% and 8.7%, respectively) and more than 156 weeks (one trial with orlistat 32 reporting a 3% TBWL compared to placebo and one subgroup analysis of a trial with tirzepatide 33 reporting 19.3% TBWL)

MadeMed is a telehealth platform - it does not provide medical care directly

1 Validation of local disruption of Gnas in Gnas fl/fl mice